androstenedione has been researched along with tamoxifen in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (19.35) | 18.7374 |
| 1990's | 29 (46.77) | 18.2507 |
| 2000's | 17 (27.42) | 29.6817 |
| 2010's | 4 (6.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Howson, JW; Watson, J | 1 |
| Beyer, C; Larsson, K; Moralí, G; Naftolin, F | 1 |
| Christodoulides, A; Ghilchik, MW; Koistinen, R; Reed, MJ; Seppälä, M; Teale, JD | 1 |
| Bogart, MH; Lance, VA | 1 |
| Hisamatsu, K; Nomura, Y; Tashiro, H | 1 |
| Adessi, G; Jouvenot, M; Marechal, G; Ordener, C; Pellerin, I; Royez, M; Vuillermoz, C | 1 |
| Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
| Distler, W; von Matthiessen, H | 1 |
| Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H | 1 |
| Becher, R; Callies, R; Friederich, P; Höffken, K; Jonat, W; Kölbel, M; Kunz, T; Possinger, K; Wagner, H; Willmanns, W | 1 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Eechaute, W; Lacroix, E; Leusen, I; Vanderstichele, H | 1 |
| Murray, M; Reidy, GF | 1 |
| Brodie, AM; Santen, RJ | 1 |
| Hampl, R; Heresová, J; Lachman, M; Stárka, L; Sulcová, J | 1 |
| Brodie, AM; Coombes, RC; Dowsett, M; Goss, P; Wing, LY | 1 |
| Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC | 1 |
| Donahoe, PK; Hutson, JM; MacLaughlin, DT | 1 |
| Smith, IE; Stuart-Harris, RC | 1 |
| Davis, TE; Rose, DP | 1 |
| Brodie, A; Savinov, A; Wang, J; Yue, W | 1 |
| Bartsch, G; el Etreby, MF; Habenicht, UF; Schröder, FH; Schweikert, HU; Senge, T; Tunn, UW | 1 |
| Purohit, P; Rao, AJ; Sharma, SC | 1 |
| Alberola Candel, V; Calabresi, F; Delozier, T; Feuilhade, F; Freue, M; Goss, P; Mauriac, L; Michel, RT; Pérez Carrión, R; Santos, R | 1 |
| Forkert, PG; Jellinck, PH; Martucci, CP; Newcombe, AM | 1 |
| Brodie, A; Yue, W | 1 |
| Bajetta, E; Bichisao, E; Buzzoni, R; Celio, L; Noberasco, C; Zilembo, N | 1 |
| Callens, M; De Coster, R; Goeminne, N; Janssens, B; Van Ginckel, R; Wouters, L | 1 |
| Cala, KM; Landrum, DP; Mahendroo, MS; Russell, DW | 1 |
| Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Luo, S; Martel, C; Mérand, Y; Sourla, A | 1 |
| Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
| Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B | 1 |
| Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P | 1 |
| Dickson, RB; El-Ashry, D; Hannum, RS; Kern, FG; Kharbanda, S; Lopez, CA; Lorant, LA; McLeskey, SW; Tobias, CA; Trock, BJ; Zhang, L | 1 |
| Andrés, E; Dufour, P; Goichot, B; Imler, M; Kurtz, JE; Schlienger, JL | 1 |
| Brodie, AM; Dehal, SS; Kupfer, D | 1 |
| Bernhard, J; Bonnefoi, H; Castiglione-Gertsch, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hürny, C; Morant, R; Schmitz, SF; Thürlimann, B | 1 |
| Soory, M; Tilakaratne, A | 2 |
| Brandi, ML; Fiorelli, G; Martineti, V; Picariello, L; Tonelli, F | 1 |
| Brodie, AM; Njar, VC | 1 |
| Dowsett, M | 1 |
| Harvey, HA; Santen, RJ | 1 |
| Damien, E; Lanyon, LE; Price, JS | 1 |
| Keller-Wood, M; Saoud, CJ; Stoner, TA; Wood, CE | 1 |
| Klinga, K; Mayer, D; Morfin, R; Schmitt, M; Schnarr, B | 1 |
| Bonneterre, J; Mauriac, L | 1 |
| Kagaya, A; Kurata, K; Morinobu, S; Takebayashi, M; Yamawaki, S | 1 |
| Adamski, J; Breitling, R; Krazeisen, A; Möller, G | 1 |
| Briand, P; Jensen, J; Kitlen, JW; Labrie, F; Lykkesfeldt, AE | 1 |
| Carlini, P; Cognetti, F; Colella, E; Di Cosimo, S; Fabi, A; Ferretti, G; Frassoldati, A; Papaldo, P; Romiti, A; Ruggeri, EM; Tomao, S; Tonachella, R | 1 |
| Kriegstein, AR; Martínez-Cerdeño, V; Noctor, SC | 1 |
| Brodie, A; Goloubeva, O; Jelovac, D; Sabnis, G; Schayowitz, A | 1 |
| Fox, J; Hamad, A; Kluk, M; Park, M; Turner, JE | 1 |
| Goss, PE; Hu, H; Qi, S | 1 |
| Contreras, CM; Gutiérrez-García, AG; Jacome-Jacome, E; Molina-Jiménez, T; Vásquez-Hernández, DI | 1 |
| Bryk, M; Chatterton, RT; Habe-Evans, M; Khan, SA; Parker, NP; Scholtens, DM | 1 |
| Botrè, F; Braganò, MC; de la Torre, X; Mazzarino, M; Molaioni, F | 1 |
| Andò, S; Barone, I; Brown, PH; Fuqua, SA; Iacopetta, D; O'Malley, BW; Rechoum, Y; Rovito, D; Weigel, NL | 1 |
| Gramapurohit, NP; Mali, PV | 1 |
8 review(s) available for androstenedione and tamoxifen
| Article | Year |
|---|---|
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen | 1986 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Humans; Male; Prostatic Hyperplasia; Tamoxifen | 1993 |
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
Aromatase inhibitors and their application in breast cancer treatment*.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Mice; Nitriles; Tamoxifen; Triazoles | 2000 |
Drug and hormone interactions of aromatase inhibitors.
Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
10 trial(s) available for androstenedione and tamoxifen
| Article | Year |
|---|---|
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Germany, West; Humans; Life Tables; Menopause; Middle Aged; Multicenter Studies as Topic; Receptors, Estrogen; Remission Induction; Tamoxifen | 1990 |
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen | 1986 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1994 |
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure | 1997 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine | 1997 |
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Quality of Life; Tamoxifen; Treatment Failure | 1999 |
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2003 |
47 other study(ies) available for androstenedione and tamoxifen
| Article | Year |
|---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Inhibition of Tamoxifen of the stimulatory action of FSH on oestradiol-17beta synthesis by rat ovaries in vitro.
Topics: Androstenedione; Animals; Culture Techniques; Estradiol; Female; Follicle Stimulating Hormone; Ovary; Pregnancy; Rats; Stilbenes; Tamoxifen; Testosterone | 1977 |
Effect of some antiestrogens and aromatase inhibitors on androgen induced sexual behavior in castrated male rats.
Topics: Aminoglutethimide; Androstenedione; Animals; Castration; Clomiphene; Drug Interactions; Ejaculation; Ethamoxytriphetol; Male; Metyrapone; Rats; Sexual Behavior, Animal; Tamoxifen; Testosterone; Time Factors | 1976 |
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer.
Topics: Aged; Androstenedione; Breast Neoplasms; Carrier Proteins; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen | 1992 |
Disruption of ovarian development in alligator embryos treated with an aromatase inhibitor.
Topics: Alligators and Crocodiles; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Estradiol; Fadrozole; Female; Imidazoles; Male; Nitriles; Ovary; Tamoxifen; Testis | 1992 |
[Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Estrone; Female; Humans; Middle Aged; Survival Rate; Tamoxifen | 1992 |
Superinduction of c-fos gene expression by estrogen in cultured guinea-pig endometrial cells requires priming by a cycloheximide-dependent mechanism.
Topics: Androstenedione; Animals; Cells, Cultured; Cycloheximide; Diethylstilbestrol; Endometrium; Estradiol; Estriol; Estrone; Female; Gene Expression; Genes, fos; Guinea Pigs; Hydrocortisone; Kinetics; RNA, Messenger; Tamoxifen; Testosterone; Transcription, Genetic | 1992 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
Effect of tamoxifen on the activity of enzymes of testicular steroidogenesis.
Topics: 20-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Dehydroepiandrosterone; Follicle Stimulating Hormone; Luteinizing Hormone; Lyases; Male; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Steroid 17-alpha-Hydroxylase; Tamoxifen; Testicular Hormones; Testis; Testosterone | 1989 |
In vitro inhibition of hepatic steroid hydroxylation by tamoxifen, a series of tamoxifen analogues and related compounds.
Topics: Androstenedione; Animals; Cytochrome P-450 Enzyme Inhibitors; Hydroxylation; Liver; Male; Pyridines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tamoxifen | 1989 |
Hormonal changes in tamoxifen treated men with idiopathic oligozoospermia.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Estradiol; Humans; Hydroxyprogesterones; Male; Oligospermia; Sex Hormone-Binding Globulin; Sperm Motility; Tamoxifen | 1988 |
Aromatase inhibitors and the treatment of breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Macaca mulatta; Mammary Neoplasms, Experimental; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Rats; Tamoxifen | 1986 |
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen | 1986 |
Steroid modulation of Mullerian duct regression in the chick embryo.
Topics: Aminoglutethimide; Androstenedione; Animals; Anti-Mullerian Hormone; Chick Embryo; Drug Interactions; Estrogen Antagonists; Estrogens; Female; Glycoproteins; Growth Inhibitors; Male; Mullerian Ducts; Norethindrone; Pyrrolidines; Tamoxifen; Testicular Hormones; Thiophenes | 1985 |
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Topics: Adrenal Cortex; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Ovary; Prednisone; Sex Hormone-Binding Globulin; Tamoxifen | 1980 |
Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Fadrozole; Female; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles; Uterus | 1995 |
Role of oestradiol-17 beta in the regulation of synthesis and secretion of human chorionic gonadotrophin by first trimester human placenta.
Topics: Androstenedione; Aromatase Inhibitors; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Female; Glycoprotein Hormones, alpha Subunit; Humans; Kinetics; Peptide Fragments; Placenta; Pregnancy; Pregnancy Trimester, First; Progesterone; RNA, Messenger; Tamoxifen | 1993 |
Distinct forms of hepatic androgen 6 beta-hydroxylase induced in the rat by indole-3-carbinol and pregnenolone carbonitrile.
Topics: Androstenedione; Androsterone; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Hydroxylation; Immunoblotting; Indoles; Liver; Male; Metyrapone; Pregnenolone Carbonitrile; Rats; Rats, Sprague-Dawley; Steroid Hydroxylases; Tamoxifen | 1994 |
MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tamoxifen; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy.
Topics: Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Remission Induction; Tamoxifen; Treatment Outcome | 1993 |
Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinogens; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Tamoxifen; Triazoles | 1996 |
Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androstenedione; Animals; Biological Assay; Decidua; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Estrogen Antagonists; Estrogens; Female; Fetal Death; Gene Expression Regulation, Enzymologic; In Situ Hybridization; Litter Size; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitriles; Placenta; RNA, Messenger; Steroids; Tamoxifen; Triazoles; Uterus | 1997 |
Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Atrophy; Benzopyrans; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Antagonists; Estrone; Female; Mice; Mice, Inbred BALB C; Organ Size; Ovariectomy; Propionates; Receptors, Estrogen; Tamoxifen; Testosterone; Uterus; Vagina | 1997 |
Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Cell Line; Chloramphenicol O-Acetyltransferase; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factors; Fulvestrant; Humans; Letrozole; Luciferases; Mice; Mice, Nude; Nitriles; Ovariectomy; Polymerase Chain Reaction; Receptors, Progesterone; Recombinant Fusion Proteins; RNA, Messenger; Tamoxifen; Transcription, Genetic; Transfection; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured | 1998 |
[Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy].
Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Mastectomy; Meningeal Neoplasms; Remission Induction; Tamoxifen; Treatment Outcome | 1999 |
The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
Topics: Androstenedione; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Activation; Liver; Male; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley; Tamoxifen | 1999 |
Androgen metabolism in response to oestradiol-17beta and progesterone in human gingival fibroblasts (HGF) in culture.
Topics: Adult; Androgens; Androstenedione; Carbon Radioisotopes; Cells, Cultured; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fibroblasts; Gingiva; Humans; Male; Middle Aged; Periodontal Diseases; Periodontitis; Progesterone; Radiopharmaceuticals; Tamoxifen; Testosterone; Wound Healing | 1999 |
Estrogen synthesis in human colon cancer epithelial cells.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Colorectal Neoplasms; Estrogen Antagonists; Estrogens; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genistein; Humans; Kinetics; Quercetin; Raloxifene Hydrochloride; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 1999 |
Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.
Topics: Androgen Antagonists; Androstenedione; Animals; Antibodies; Aromatase Inhibitors; Cells, Cultured; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Flutamide; Fulvestrant; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Osteoblasts; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Stress, Mechanical; Tamoxifen; Testosterone; Thymidine | 2000 |
Estrogen and androgen influence hypothalamic AVP and CRF concentrations in fetal and adult sheep.
Topics: Androgens; Androstenedione; Animals; Arginine Vasopressin; Case-Control Studies; Corticotropin-Releasing Hormone; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Hypothalamus; Pregnancy; Sheep; Tamoxifen | 2001 |
Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Mitogens; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2001 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Tamoxifen | 2000 |
Effect of beta-estradiol on voltage-gated Ca(2+) channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Androstenedione; Animals; Azlocillin; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Corticosterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dizocilpine Maleate; Estradiol; Estrogen Antagonists; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Hippocampus; Imidazolidines; N-Methylaspartate; Neurons; Nifedipine; Rats; Rats, Wistar; Tamoxifen | 2001 |
Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstane-3,17-diol; Androstenedione; Androsterone; Anticarcinogenic Agents; Binding Sites; Diet; Enzyme Inhibitors; Estrogens, Non-Steroidal; Flavonoids; Humans; Hydroxylation; Hydroxyprostaglandin Dehydrogenases; Isoflavones; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Phytoestrogens; Plant Preparations; Plants, Edible; Recombinant Fusion Proteins; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Testosterone | 2002 |
Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Division; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; Humans; Ligands; Membrane Proteins; Piperidines; Presenilin-2; Protein Binding; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Time Factors; Tumor Cells, Cultured | 2003 |
Modulation of androgen metabolism by phenytoin, oestradiol and tamoxifen in human gingival fibroblasts.
Topics: Adult; Androstenedione; Anticonvulsants; Cells, Cultured; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fibroblasts; Gingiva; Gingival Overgrowth; Humans; Male; Middle Aged; Phenytoin; Tamoxifen; Testosterone | 2003 |
Estradiol stimulates progenitor cell division in the ventricular and subventricular zones of the embryonic neocortex.
Topics: Androstenedione; Animals; Animals, Newborn; Aromatase; Blotting, Western; Cell Division; Cerebral Ventricles; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation, Developmental; Immunohistochemistry; In Situ Hybridization; In Vitro Techniques; Male; Mice; Neocortex; Pregnancy; Prenatal Exposure Delayed Effects; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells; Tamoxifen; Time Factors | 2006 |
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
Topics: Androstadienes; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor Modulators; Humans; Letrozole; Mice; Mice, Nude; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Tamoxifen; Triazoles; Wortmannin | 2007 |
The effects of aromatase inhibitors and selective estrogen receptor modulators on eye development in the zebrafish (Danio rerio).
Topics: Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Clomiphene; Embryo, Nonmammalian; Embryonic Development; Estrogens; Eye; Retina; Selective Estrogen Receptor Modulators; Tamoxifen; Zebrafish | 2007 |
Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Body Weight; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Compressive Strength; Epithelial Cells; Estrogen Antagonists; Female; Femur; Humans; Lipids; Lumbar Vertebrae; Ovariectomy; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Tamoxifen; Toremifene; Uterus | 2009 |
Testosterone reduces cumulative burying in female Wistar rats with minimal participation of estradiol.
Topics: Androstenedione; Animals; Anti-Anxiety Agents; Aromatase Inhibitors; Estradiol; Estrogen Antagonists; Female; GABA Antagonists; GABA-A Receptor Antagonists; Motor Activity; Picrotoxin; Rats; Rats, Wistar; Receptors, GABA-A; Tamoxifen; Testosterone | 2009 |
Breast ductal lavage for assessment of breast cancer biomarkers.
Topics: Adult; Aged; Analysis of Variance; Androstenedione; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cathepsin D; Dehydroepiandrosterone; Epidermal Growth Factor; Estradiol; Estrone; Female; Humans; Immunoassay; Middle Aged; Postmenopause; Premenopause; Progesterone; Tamoxifen; Therapeutic Irrigation | 2010 |
Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
Topics: Administration, Oral; Adult; Androgens; Androstenedione; Biomarkers; Clomiphene; Doping in Sports; Epitestosterone; Female; Humans; Male; Performance-Enhancing Substances; Reference Standards; Selective Estrogen Receptor Modulators; Sex Factors; Substance Abuse Detection; Tamoxifen; Testosterone; Toremifene | 2011 |
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.
Topics: Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; MCF-7 Cells; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Androgen; Tamoxifen; Triazoles | 2014 |
Are sex steroids essential for gonadal differentiation of the ornate frog, Microhyla ornata?
Topics: Androstenedione; Animals; Anura; Aromatase Inhibitors; Cell Differentiation; Estradiol; Female; Gonadal Steroid Hormones; Gonads; Larva; Male; Metamorphosis, Biological; Ovary; Sex Differentiation; Sex Ratio; Tamoxifen; Testis; Testosterone | 2016 |